Toshko Lissitchkov

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy

John Pasi, Savita Rangarajan, Pencho Georgiev et al. · New England Journal of Medicine · 2017 · 345 citations · Full text

Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors

Barbara A. Konkle, Liselotte S. Ebbesen, Elisabeth Erhardtsen et al. · Journal of Thrombosis and Haemostasis · 2007 · 325 citations · Full text

Thrombosis, Secondary Prophylaxis, Hematology +10

Randomized, controlled, parallel-group trial of routine prophylaxis vs. on-demand treatment with sucrose-formulated recombinant factor VIII in adults with severe hemophilia A (SPINART)

Marilyn J. Manco‐Johnson, Christine L. Kempton, Mark T. Reding et al. · Journal of Thrombosis and Haemostasis · 2013 · 197 citations · Full text

Parallel-group Trial, Severe Hemophilia A, Hematology +4

Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase <scp>III</scp> trial

Wolfgang Knauf, Toshko Lissitchkov, Ali Aldaoud et al. · British Journal of Haematology · 2012 · 107 citations · Full text

Targeting of antithrombin in hemophilia A or B with investigational siRNA therapeutic fitusiran—Results of the phase 1 inhibitor cohort

John Pasi, Toshko Lissitchkov, Vasily Mamonov et al. · Journal of Thrombosis and Haemostasis · 2021 · 93 citations · Full text